Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

8.3K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.3K
The Tumor Microenvironment02:17

The Tumor Microenvironment

3.2K
3.2K
Overview of Exosomes01:36

Overview of Exosomes

4.0K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
4.0K
Metastasis02:30

Metastasis

7.0K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
7.0K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

6.4K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.4K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

7.6K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Inhibition of c-FLIP alongside TRAIL treatment suppresses prostate cancer stem cell activity.

British journal of cancer·2026
Same author

FUT8 Is a Critical Driver of Prostate Tumour Growth and Can Be Targeted Using Fucosylation Inhibitors.

Cancer medicine·2025
Same author

ST6GAL1-mediated aberrant sialylation promotes prostate cancer progression.

The Journal of pathology·2023
Same author

Upregulation of GALNT7 in prostate cancer modifies O-glycosylation and promotes tumour growth.

Oncogene·2023
Same author

The architecture of clonal expansions in morphologically normal tissue from cancerous and non-cancerous prostates.

Molecular cancer·2022
Same author

ETS transcription factor ELF3 (ESE-1) is a cell cycle regulator in benign and malignant prostate.

FEBS open bio·2022

Related Experiment Video

Updated: Apr 18, 2026

A Proximal Culture Method to Study Paracrine Signaling Between Cells
08:17

A Proximal Culture Method to Study Paracrine Signaling Between Cells

Published on: August 28, 2018

10.2K

Carcinoma-derived exosomes modify microenvironment.

Norman J Maitland1

  • 1YCR Cancer Research Unit, Department of Biology, University of York, York, United Kingdom.

Oncotarget
|January 31, 2015
PubMed
Summary
This summary is machine-generated.

Cancer exosomes can change mesenchymal stem cells into cells that help tumors grow and spread. This study comments on research showing how cancer cell communication drives tumor progression.

More Related Videos

A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells
11:15

A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells

Published on: May 6, 2018

10.7K
Preparation of Exosomes for siRNA Delivery to Cancer Cells
09:59

Preparation of Exosomes for siRNA Delivery to Cancer Cells

Published on: December 5, 2018

26.3K

Related Experiment Videos

Last Updated: Apr 18, 2026

A Proximal Culture Method to Study Paracrine Signaling Between Cells
08:17

A Proximal Culture Method to Study Paracrine Signaling Between Cells

Published on: August 28, 2018

10.2K
A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells
11:15

A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells

Published on: May 6, 2018

10.7K
Preparation of Exosomes for siRNA Delivery to Cancer Cells
09:59

Preparation of Exosomes for siRNA Delivery to Cancer Cells

Published on: December 5, 2018

26.3K

Area of Science:

  • Cancer biology
  • Cellular differentiation
  • Tumor microenvironment

Background:

  • Exosomes are key mediators of intercellular communication in cancer.
  • Mesenchymal stem cells (MSCs) are influenced by the tumor microenvironment.
  • Cancer-derived exosomes can alter the behavior of surrounding cells.

Discussion:

  • This study comments on research showing cancer exosomes induce MSCs to differentiate into pro-angiogenic and proinvasive myofibroblasts.
  • This differentiation promotes tumor angiogenesis (new blood vessel formation) and invasion, facilitating metastasis.
  • The findings suggest a critical role for exosome-mediated intercellular communication in cancer progression.

Key Insights:

  • Cancer exosomes actively reprogram mesenchymal stem cells.
  • Induced MSCs acquire myofibroblast characteristics, supporting tumor vascularization and invasion.
  • This highlights a significant pathway through which tumors manipulate the host microenvironment.

Outlook:

  • Further research into exosome-MSC interactions could reveal new therapeutic targets.
  • Understanding this crosstalk may lead to strategies to inhibit tumor angiogenesis and metastasis.
  • Targeting exosome content or MSC differentiation could offer novel anti-cancer therapies.